Founded in 1992, Beilu is mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. It has around 650 employees with 0.82 Bn/￥ revenue in 2019. Beilu provides complete Contrast Media products suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading manufacturer in the Contrast Media field in China. It is one of the 1st batches of listed enterprises in GEM of SZSE (Ticker: 300016.SZ) in China.

Beilu's main products are Contrast Media, Anti-anxiety traditional Chinese medicine, and Anti-diabetic drugs to benefit people and improve their quality of life. Contrast Media are widely used to improve pictures of the inside of the body produced by X-rays, computed tomography (CT), magnetic resonance (MR) imaging, etc. Anti-anxiety traditional Chinese medicine is the original product with Chinese patent to contribute to improving the physical and mental status. And Anti-diabetic drugs are hypoglycemic drugs for the treatment of type 2 diabetes.